A review of the biological properties and metabolic disposition of the new analgesic agent, meptazinol.
D000042:Absorption; D000700:Analgesics / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D000889:Anti-Arrhythmia Agents; D001341:Autonomic Nervous System / Q000187:drug effects; D001381:Azepines / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D001711:Biotransformation; D002490:Central Nervous System / Q000187:drug effects; D004064:Digestive System / Q000187:drug effects; D004361:Drug Tolerance; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D007928:Lethal Dose 50; D009292:Narcotic Antagonists; D009294:Narcotics; D012119:Respiration / Q000187:drug effects; D019966:Substance-Related Disorders; D014018:Tissue Distribution
D000700:Analgesics; D000889:Anti-Arrhythmia Agents; D001381:Azepines; D009292:Narcotic Antagonists; D009294:Narcotics